Stream Bio, a UK-based company that develops and manufactures a range of innovative life science products, is delighted to announce the launch of its new rapid conjugation kit, LINKBRIGHT™, which will allow quick and easy linkage of Conjugated Polymer Nanoparticles (CPNs™) to antibodies and oligonucleotides.
Stream Bio, a UK-based company that develops and manufactures a range of innovative life science products, is delighted to announce... View Article
Alongside Chelsea Technologies, Stream Bio has formed a joint venture, Brightline Diagnostics, to create a unique platform that can be... View Article
Stream Bio, a company that develops and manufactures a range of transformative bioimaging molecular probes, is delighted to announce a... View Article
Stream Bio, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, is delighted to announce the launch of five additional Conjugated Polymer Nanoparticles (CPNs™) to their product range.
Stream Bio, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, is delighted to announce that its Conjugated Polymer Nanoparticles (CPNs™) are now available to purchase worldwide through Sigma Aldrich.
Stream Bio has further expanded the European distribution network for its Conjugated Polymer Nanoparticles (CPNs™). A new agreement with DBA Italia will make Stream’s innovative bioimaging probes available for purchase in Italy.
Stream Bio, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, has won funding in the highly competitive Innovate UK, manufacturing and materials Innovation Loan Competition.
Stream Bio, a company that develops and manufactures a range of revolutionary bioimaging molecular probes,has launched its new range of Streptavidin-linked CPNs™ onto the market. These Streptavidin Conjugates can be used for the detection of various biomolecules and will complement Stream’s current portfolio of CPN™ molecular probes.
Stream Bio has been shortlisted for the prestigious Bionow Awards 2018 in both the Product of the Year and Start Up of the Year categories. These nominations reflect Stream Bio’s excellence in innovation and entrepreneurship for its novel CPN™ technology.
Stream Bio Ltd is expanding the distribution network of its transformative Conjugated Polymer Nanoparticle (CPN™) products across Europe. New agreements with life science distributors CliniSciences and Biotrend will make its products available for purchase in France and Germany respectively.
Stream Bio Ltd has won the highly esteemed Institute of Physics Business Start-Up Award. This reward reflects Stream Bio’s novel CPN™ technology and celebrates its entrepreneurship and excellence in innovation.
Stream Bio Ltd has been shortlisted for the Materials and Enabling Technology award within the Royal Society of Chemistry’s Emerging Technologies Competition 2018.
ream Bio Ltd has today launched its transformative Conjugated Polymer Nanoparticle (CPN™) products with life science distributors 2BScientific.
Stream Bio Ltd, a company that develops and manufactures revolutionary bioimaging products and molecular probes, today announced the promising development of its revolutionary Conjugated Polymer Nanoparticle (CPN™) products at Bionow’s BioFocus Conference.
Stream Bio Ltd today presented its revolutionary Conjugated Polymer Nanoparticle (CPN™) technology at the opening of the Centre for Process Innovation’s (CPI) National Formulation Centre.
Stream Bio Ltd has revealed it will be joining Theresa May alongside selected UK businesses on an international trade visit to China.
Stream Bio Ltd has revealed how its unique conjugated polymer nanoparticles (CPN™) can be used in imaging at the EPRISE ‘Photonics in the Medical Technologies and Pharmaceutical Markets’ event in Cardiff.